Pallas Capital Advisors LLC Natera, Inc. Transaction History
Pallas Capital Advisors LLC
- $2.21 Billion
- Q4 2024
A detailed history of Pallas Capital Advisors LLC transactions in Natera, Inc. stock. As of the latest transaction made, Pallas Capital Advisors LLC holds 6,865 shares of NTRA stock, worth $1 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
6,865
Previous 6,469
6.12%
Holding current value
$1 Million
Previous $822,000
32.12%
% of portfolio
0.05%
Previous 0.03%
Shares
3 transactions
Others Institutions Holding NTRA
# of Institutions
636Shares Held
123MCall Options Held
821KPut Options Held
1.01M-
Vanguard Group Inc Valley Forge, PA12.3MShares$1.8 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY6.77MShares$991 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.74MShares$986 Million0.12% of portfolio
-
Jpmorgan Chase & CO New York, NY6.7MShares$980 Million0.09% of portfolio
-
Farallon Capital Management LLC San Francisco, CA4.43MShares$648 Million3.74% of portfolio
About Natera, Inc.
- Ticker NTRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 96,957,400
- Market Cap $14.2B
- Description
- Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...